• Search
  • Advanced Search
Clin Mol Hepatol > Accepted Articles
Editorial
Metabolic Health in Antiviral Era of Chronic Hepatitis B
Shang-Chin Huang1,2,3,4, Jia-Horng Kao2,3,4
1Department of Internal Medicine, National Taiwan University Hospital Bei-Hu Branch, Taipei, Taiwan
2Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
3Hepatitis Research Center, National Taiwan University Hospital, Taipei, Taiwan
4Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan
Correspondence :  Jia-Horng Kao ,
Tel: 886-2-23123456 Ext. 267307, Fax: 886-2-23825962, Email: kaojh@ntu.edu.tw
Received: April 3, 2025   Accepted: April 8, 2025
TOOLS
METRICS Graph View
  • 0 Crossref
  •  0 Scopus
  • 211 View
  • 17 Download
Related articles

Advancing Metabolic Risk Profiling in Chronic Hepatitis B

Correspondence to editorial “Metabolic health in antiviral era of chronic hepatitis B”

Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study2024 July;30(3)

The role of different viral biomarkers on the management of chronic hepatitis B2023 April;29(2)

Novel biomarkers for the management of chronic hepatitis B2020 July;26(3)

Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1551
TOTAL : 2693345
Close layer